Co-Immunoprecipitation Now Available in Profacgen
Profacgen announced the launch of Co-Immunoprecipitation service, aiming to provide its customers the latest techniques.
(firmenpresse) - Profacgen, a world leading biotech company that offers a full range of biopharmaceutical development and bio-manufacturing services that cover strategic consultancy, world-class process development, cGMP manufacturing, and analytical development, announced the launch of Co-Immunoprecipitation service, aiming to provide its customers the latest techniques.
Co-immunoprecipitation (Co-IP) is a popular technique to identify physiologically relevant protein-protein interactions by using target protein-specific antibodies to indirectly capture proteins that are bound to a specific target protein. These protein complexes can then be analyzed to identify new binding partners, binding affinities, the kinetics of binding and the function of the target protein.
Based on the specific immunological interaction between the bait protein and its antibody, Co-IP has become an effective and reliable method in detecting the physiological interaction between proteins.
“Since foundation, Profacgen is always strives to provide our customers product and services with the best quality and the most reasonable prices. We are always improving our technologies and systems. We hope these changes can make a contribution to advancing the research missions of our valued customers.” commented Crystal, the chief marketing staff in Profacgen.
According to its official speaker, this novel service has the following advantages: customized service for each client’s requirements; highly reproducible experimental results; short turn-around time; best price in the market.
To know more information about this newly launched service in Profacgen, you can visit http://www.profacgen.com/Co-Immunoprecipitation-Co-IP.htm
About Profacgen
Profacgen provides process development and cGMP manufacturing services for biological active ingredients. We have ready access to state-of-the-art biopharmaceutical product development and manufacturing facilities and our staff scientists have demonstrable expertise in all aspects of biopharmaceutical manufacturing, from facility design and operation to the ability to provide best advice relating to product development. We also save our clients a great deal of time with bioprocess scale-up services. Our fermentation laboratories are equipped with state-of-the-art fermentors and bioreactors that enable us to express protein in large scale. Our customers can choose to enter into the protein expression pipeline at any stage depending on their needs.
Contact:
Profacgen
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-448-7888
Fax: 1-631-938-8127
Email: info(at)profacgen.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.03.2016 - 09:26 Uhr
Sprache: Deutsch
News-ID 1424853
Anzahl Zeichen: 2884
contact information:
Contact person:
Town:
Phone:
Kategorie:
Healthcare & Medical
Typ of Press Release: bitte
type of sending: Veröffentlichung
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Co-Immunoprecipitation Now Available in Profacgen
"
steht unter der journalistisch-redaktionellen Verantwortung von
Profacgen (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
